Online Education Opportunities

May 17/May 18 and May 24/May 25
11:45am - 4:00pm MDT

Join us in May to learn about innovations in the Wyoming healthcare landscape and share information with professionals across the state on topics impacting rural care.

REGISTER HERE 

Thursday, June 3, 2021 12:30PM
Pediatric Ophthalmology for the Pediatrician by Lauren Mehner, MD, MPH, and Michael Puente, Jr., MD. Virtual conference  
REGISTRATION COMING SOON

Wednesday, May 19, 2021 6PM - 7PM

Sleep Apnea, More Than Just Tonsils CME by Stephen Newton, MD, Pediatric Otolaryngologist, Children's Hospital Colorado  

REGISTER HERE

Monday, May 24 at 6 pm MT

Register here: https://ucdenver.co1.qualtrics.com/jfe/form/SV_1SuLoGf07JM10Ro

May 24/May 25
11:45am - 4:00pm MDT

Join us in May to learn about innovations in the Wyoming healthcare landscape and share information with professionals across the state on topics impacting rural care.

REGISTER HERE 

Thursday, June 10, 2021 at 11:30 am

The Wyoming PAL Program is hosting a pediatric mental health webinar for treating providers. This conference was formerly to take place in Cheyenne, WY but has been moved to an online platform.

REGISTER HERE 

May 24/May 25
11:45am - 4:00pm MDT

Join us in May to learn about innovations in the Wyoming healthcare landscape and share information with professionals across the state on topics impacting rural care.

REGISTER HERE 

The program High-Risk Patients with COVID-19: Outpatient Management to Prevent Progression will provide clinicians who manage outpatients with COVID-19 with a review of the most current management guidelines and information on the mechanism of action, efficacy and safety data, and patient eligibility for the monoclonal antibodies that have received emergency use authorization (EUA) by the FDA to treat outpatients with COVID-19.

5/27/21 - 4:00 - 5:00 PM ET
6/1/21 - 1:15 - 2:15 PM ET 
6/5/21 - 8:00 - 9:00 AM ET
6/9/21 - 12:00 - 1:00 PM ET
6/29/21 - 8:00 - 9:00 AM ET

REGISTER HERE 

The program High-Risk Patients with COVID-19: Outpatient Management to Prevent Progression will provide clinicians who manage outpatients with COVID-19 with a review of the most current management guidelines and information on the mechanism of action, efficacy and safety data, and patient eligibility for the monoclonal antibodies that have received emergency use authorization (EUA) by the FDA to treat outpatients with COVID-19.

5/27/21 - 4:00 - 5:00 PM ET
6/1/21 - 1:15 - 2:15 PM ET 
6/5/21 - 8:00 - 9:00 AM ET
6/9/21 - 12:00 - 1:00 PM ET
6/29/21 - 8:00 - 9:00 AM ET

REGISTER HERE 

The program High-Risk Patients with COVID-19: Outpatient Management to Prevent Progression will provide clinicians who manage outpatients with COVID-19 with a review of the most current management guidelines and information on the mechanism of action, efficacy and safety data, and patient eligibility for the monoclonal antibodies that have received emergency use authorization (EUA) by the FDA to treat outpatients with COVID-19.

5/27/21 - 4:00 - 5:00 PM ET
6/1/21 - 1:15 - 2:15 PM ET 
6/5/21 - 8:00 - 9:00 AM ET
6/9/21 - 12:00 - 1:00 PM ET
6/29/21 - 8:00 - 9:00 AM ET

REGISTER HERE 

The program High-Risk Patients with COVID-19: Outpatient Management to Prevent Progression will provide clinicians who manage outpatients with COVID-19 with a review of the most current management guidelines and information on the mechanism of action, efficacy and safety data, and patient eligibility for the monoclonal antibodies that have received emergency use authorization (EUA) by the FDA to treat outpatients with COVID-19.

5/27/21 - 4:00 - 5:00 PM ET
6/1/21 - 1:15 - 2:15 PM ET 
6/5/21 - 8:00 - 9:00 AM ET
6/9/21 - 12:00 - 1:00 PM ET
6/29/21 - 8:00 - 9:00 AM ET

REGISTER HERE 

Monday, June 14 at 6 pm MT

Register here: https://ucdenver.co1.qualtrics.com/jfe/form/SV_1BbnHiVV6A13AZU

The program High-Risk Patients with COVID-19: Outpatient Management to Prevent Progression will provide clinicians who manage outpatients with COVID-19 with a review of the most current management guidelines and information on the mechanism of action, efficacy and safety data, and patient eligibility for the monoclonal antibodies that have received emergency use authorization (EUA) by the FDA to treat outpatients with COVID-19.

5/27/21 - 4:00 - 5:00 PM ET
6/1/21 - 1:15 - 2:15 PM ET 
6/5/21 - 8:00 - 9:00 AM ET
6/9/21 - 12:00 - 1:00 PM ET
6/29/21 - 8:00 - 9:00 AM ET

REGISTER HERE 

August 1-6, 2021 Virtual or In-Person
38th Annual Conference on Pediatric Infectious Diseases, Offered Virtually or In-Person
REGISTER HERE

August 1-6, 2021 Virtual or In-Person
38th Annual Conference on Pediatric Infectious Diseases, Offered Virtually or In-Person
REGISTER HERE

August 1-6, 2021 Virtual or In-Person
38th Annual Conference on Pediatric Infectious Diseases, Offered Virtually or In-Person
REGISTER HERE

August 1-6, 2021 Virtual or In-Person
38th Annual Conference on Pediatric Infectious Diseases, Offered Virtually or In-Person
REGISTER HERE

August 1-6, 2021 Virtual or In-Person
38th Annual Conference on Pediatric Infectious Diseases, Offered Virtually or In-Person
REGISTER HERE

August 1-6, 2021 Virtual or In-Person
38th Annual Conference on Pediatric Infectious Diseases, Offered Virtually or In-Person
REGISTER HERE